Login
Communauté Vinci
Extérieur
Si votre nom d'utilisateur ne se termine pas par @vinci.be ou @student.vinci.be, utilisez le formulaire ci-dessous pour accéder à votre compte de lecteur.
Titre : | A Randomized Controlled Trial on the Effects of Low-Dose Extracorporeal Shockwave Therapy in Patients With Knee Osteoarthritis (2019) |
Auteurs : | Zongye Zhong ; Bangzhong Liu ; Guanghua Liu |
Type de document : | Article |
Dans : | Archives of Physical Medicine and Rehabilitation (Vol. 100, n° 9, 2019) |
Article en page(s) : | p. 1695-1702 |
Langues: | Anglais |
Descripteurs : |
HE Vinci Cartilage ; Essai contrôlé randomisé ; Gonarthrose ; Rééducation et réadaptation ; Traitement par ondes de choc extracorporelles |
Résumé : |
Objective
To test the efficacy of low-dose extracorporeal shockwave therapy (ESWT) on osteoarthritis knee pain, lower limb function, and cartilage alteration for patients with knee osteoarthritis. Design Randomized controlled trial with placebo control. Setting Outpatient physical therapy clinics within a hospital network. Participants Eligible volunteers (N=63) with knee osteoarthritis (Kellgren-Lawrence grade II or III) were randomly assigned to 2 groups. Interventions Patients in the experimental group received low-dose ESWT for 4 weeks while those in the placebo group got sham shockwave therapy. Both groups maintained a usual level of home exercise. Main Outcome Measures Knee pain and physical function were measured using a visual analog scale (VAS), the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), and the Lequesne index at baseline, 5 weeks, and 12 weeks. Cartilage alteration was measured analyzing the transverse relaxation time (T2) mapping. Results The VAS score, WOMAC, and Lequesne index of the ESWT group were significantly better than those of the placebo group at 5 and 12 weeks (P<.05 both groups showed improvement in pain and disability scores over the follow-up period terms of imaging results there was no significant difference t2 values between during trial although eswt group at weeks significantly increased compared to those baseline number prevalence adverse effects were similar serious side found.> Conclusions A 4-week treatment of low-dose ESWT was superior to placebo for pain easement and functional improvement in patients with mild to moderate knee osteoarthritis but had some negative effects on articular cartilage. |
Disponible en ligne : | Oui |
En ligne : | https://login.ezproxy.vinci.be/login?url=https://www.sciencedirect.com/science/article/pii/S0003999319303892 |